Mumbai, India

Devki Moje

USPTO Granted Patents = 2 


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Devki Moje in the Pharmaceutical Field

Introduction

Devki Moje is a prominent inventor based in Mumbai, India, known for her significant contributions to the pharmaceutical industry. With a focus on developing novel compounds for the treatment of thrombo-embolism and cardiovascular diseases, she holds two patents that exemplify her innovative spirit and dedication to improving healthcare.

Latest Patents

One of Devki's latest patents involves the discovery of anti-thrombotic compounds known as (7aS,2'S)-2-oxoclopidogrel and its pharmaceutically acceptable salts. These compounds are crucial for the treatment and prevention of thrombo-embolism and cardiovascular conditions. Additionally, she has developed solid forms of methyl (7aS,2'S)-2-(2-chlorophenyl)-2-(2,4,5,6,7,7a-hexahydrothieno[3,2-c]-5-pyridin-2-one)acetate, which further emphasizes her dedication to advancing therapeutic options in this vital area of medicine.

Career Highlights

As a key member of Ipca Laboratories Limited, Devki Moje has played a crucial role in the research and development of new pharmaceutical solutions. Her innovative work within the company has positioned her as an influential figure in the field, contributing to the company's reputation for excellence in pharmaceutical manufacturing and research.

Collaborations

Devki collaborates closely with her colleagues, including Ashok Kumar and Satish Rajanikant Soudagar, fostering a collaborative environment where creativity and innovation thrive. Together, they are working on cutting-edge research endeavors aimed at developing effective treatments for various health conditions.

Conclusion

In conclusion, Devki Moje's innovative contributions to the pharmaceutical industry highlight her role as a significant inventor in Mumbai. Through her patents and collaborative efforts at Ipca Laboratories Limited, she is making considerable strides in the fight against cardiovascular diseases and thrombo-embolism, ultimately improving patient outcomes and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…